Director at Pacific Biosciences (PACB) receives 223,492 stock options grant
Rhea-AI Filing Summary
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. director Hannah Valantine received a grant of stock options covering 223,492 shares of common stock. The options have an exercise price of $1.58 per share and expire on June 3, 2036.
The options will vest monthly over one year, or earlier on the date of the next annual meeting of the company’s stockholders after the grant date, as long as she continues serving as a director. Following this grant, she holds 223,492 derivative securities directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Valantine Hannah
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 223,492 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 223,492 shares (Direct)
Footnotes (1)
- F1. The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates.
Key Figures
Options granted: 223,492 options
Exercise price: $1.58 per share
Underlying shares: 223,492 common shares
+3 more
6 metrics
Options granted
223,492 options
Stock Option grant to director on June 3, 2026
Exercise price
$1.58 per share
Conversion or exercise price of stock options
Underlying shares
223,492 common shares
Underlying security shares for the option grant
Post-transaction derivative holdings
223,492 derivative securities
Total derivative securities following the grant
Option expiration
June 3, 2036
Expiration date of the stock options
Vesting schedule
Monthly over 1 year
Vests monthly or earlier at next annual stockholders’ meeting
Key Terms
Stock Option (right to buy), conversion or exercise price, vest monthly, annual meeting of the Company's stockholders
4 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
conversion or exercise price financial
"conversion_or_exercise_price: 1.5800"
vest monthly financial
"The shares subject to the option will vest monthly over one (1) year"
annual meeting of the Company's stockholders financial
"on the date of the next annual meeting of the Company's stockholders"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did PACB director Hannah Valantine receive in this Form 4 filing?
Hannah Valantine received a grant of stock options for 223,492 shares. These options give her the right to buy PACB common stock at a fixed exercise price if they vest and she chooses to exercise.
What is the exercise price of the options granted to PACB director Hannah Valantine?
The options have an exercise price of $1.58 per share. This means she can purchase PACB common stock at $1.58 per share once the options vest and before they expire, regardless of the market price at that time.
How do the PACB stock options granted to Hannah Valantine vest?
The options vest monthly over one year, provided she remains a director. Vesting may end earlier on the date of the next annual meeting of the company’s stockholders after the grant date, if that occurs before the full year.
When do the PACB stock options granted to Hannah Valantine expire?
The options expire on June 3, 2036. She must exercise any vested portion before that expiration date; otherwise, unexercised options will lapse and no longer allow her to purchase PACB shares.
How many PACB derivative securities does Hannah Valantine hold after this transaction?
After this grant, she holds 223,492 derivative securities directly. These represent stock options tied to PACB common shares, which she may choose to exercise in the future if they are vested and in force.